C-C chemokine receptor 2 expression by circulating monocytes influences atherosclerosis in patients on chronic hemodialysis

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 3, 2009, Pages 205-212

  Okumoto, Satoshi ^a   Taniguchi, Yoshihiko ^b   Nakashima, Ayumu ^a   Masaki, Takao ^a   Ito, Takafumi ^c   Ogawa, Takahiko ^d   Takasugi, Norihisa ^e   Kohno, Nobuoki ^a   Yorioka, Noriaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^e Hakuai Hospital   (Japan)

Author keywords

Atherosclerosis; C C chemokine receptor 2; Cardio ankle vascular index; Hemodialysis; Intima media thickness

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ANKLE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ATHEROSCLEROSIS; BLOOD LEVEL; CAROTID ARTERY; CIRCULATION; CONFERENCE PAPER; CONTROL GROUP; CONTROLLED STUDY; EVALUATION; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; CAROTID ARTERIES; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, CCR2; REGRESSION ANALYSIS; RENAL DIALYSIS; TUNICA INTIMA; TUNICA MEDIA;

EID: 66549100184     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00658.x     Document Type: Conference Paper

References (30)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Eng J Med 1974 290 : 690 701.
2. Nakai S, Wada A, Kitaoka T et al. An overview of regular dialysis treatment in Japan (as of 31 December 2004). Ther Apher Dial 2006 10 : 476 97.
3. Navab M, Imes SS, Hama SY et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991 88 : 2039 46.
4. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein 1 in human atheromatous plaques. J Clin Invest 1991 88 : 1121 7.
5. Ylä-Herttuala S, Lipton BA, Rosenfeld ME et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991 88 : 5252 6.
6. Yu X, Dluz S, Graves DT et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 1992 89 : 6953 7.
7. Cushing SD, Berliner JA, Valente AJ et al. Minimally modified low density lipoprotein induces monocyte chemoattractant protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990 87 : 5134 8.
8. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994 91 : 2752 6.
9. Mackay CR. Chemokine receptors and T cell chemotaxis. J Exp Med 1996 91 : 799 802. (Pubitemid 26313537)
10. Charo IF, Reters W. Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization. Microcirculation 2003 10 : 259 64.
11. -/- mice reveals a role for Chemokines in the initiation of atherosclerosis. Nature 1998 394 : 894 7.
12. Dawson TC, Kuziel WA, Osahar TA, Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 1999 143 : 205 11.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
14. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 1993 13 : 1404 11.
15. Hosoi M, Nishizawa Y, Kogawa K et al. Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. Circulation 1996 94 : 704 7.
16. Kubozono T, Miyata M, Ueyama K et al. Clinical significance and reproducibility of new arterial distensibility index. Circ J 2007 71 : 89 94. (Pubitemid 46045556)
17. Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006 13 : 101 7.
18. Motobe K, Tomiyama H, Koji Y et al. Cut-off value of the ankle-brachial pressure index at which the accuracy of brachial-ankle pulse wave velocity measurement is diminished. Circ J 2005 69 : 55 60. (Pubitemid 40139608)
19. Nakashima A, Yorioka N, Asakimori Y et al. Different risk factors for the maximum and the mean carotid intima-media thickness in hemodialysis patients. Intern Med 2003 42 : 1095 9.
20. Asakimori Y, Yorioka N, Tanaka J, Kohno N. Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients. Am J Kidney Dis 2003 41 : 822 32.
21. Okura T, Watanabe S, Kurata M et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res 2007 30 : 335 40.
22. Gerrity RG, Naito HK. Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. Artery 1980 8 : 208 14.
23. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1984 4 : 323 40.
24. Faruqi RM, DiCorleto PE. Mechanisms of monocyte recruitment and accumulation. Br Heart J 1993 69 : S19 29.
25. Egashira K. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension 2003 41 : 834 41.
26. Kusano KF, Nakamura K, Kusano H et al. Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis. Circ J 2004 68 : 671 6.
27. Han KH, Han KO, Green SR, Quehenberger O. Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia; different effects of plasma lipoproteins on monocyte function. J Lipid Res 1999 40 : 1053 63.
28. Pertosa G, Simone S, Soccio M et al. Coagulation cascade activation causes CC chemokine receptor-2 gene expression and mononuclear cell activation in hemodialysis patients. J Am Soc Nephrol 2005 16 : 2477 86.
29. Cozzolino M, Dusso AS, Slatopolsky E. Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 2001 12 : 2511 16.
30. Stenvinkel P, Heimbürger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999 55 : 1899 911.